Clinical evaluation and disease management of PI-RADS 3 lesions. Analysis from a single tertiary high-volume center.
Ettore Di TrapaniGennaro MusiMatteo FerroGiovanni CordimaFrancesco Alessandro MistrettaStefano LuzzagoRoberto BianchiGabriele CozziSarah AlessiMichele CatellaniDeliu Victor MateiBarbara Alicja Jereczek-FossaGiuseppe PetraliaOttavio De CobelliPublished in: Scandinavian journal of urology (2020)
mpMRI-detected PI-RADS 3 lesions should be sent to a prostate biopsy if other clinical parameters suggest the presence of a PCa. In case of diagnosis of a PCa, patients should undergo confirmatory biopsy before being included in AS protocols to avoid underestimation of a CS disease.